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|sjutritional Implications of Liver Transplantation

Jeanette M. Hasse, MS, RD, LD, CNSD'
Malnutrition is a common problem of patients undergoing liver transplantation. To treat malnutrition, it must first he identified through a nutritional assessment. Because many objective nutrittonal
assessment parameters have limitations in end-stage liver disease, subjective nutritional indicators
may be used as an alternative. Nutritional needs following transplantation are categorized as short
and long term. The short-term nutritional goal, anabolism, can be complicated by the nutritional
status ofthe patient, surgical procedures, and necessary medications. The increased nutrient needs
during the early posttransplant phase require particular nutritional support. Nutrition-related
problems following transplantation may include obesity, hyperlipidemia. hypertension, diabetes
mellitus. hyperkalemia, edema, or osteoporosis. Dietetic advice relative to the nutritional needs ofthe
liver transplant recipient can improve hoth the short- and long-term outcomes. (Henry Ford Hosp
MedJ 1990:38:235-40)

iver transplantation has becorae a therapeutic option for
hundreds of victiras of hepatic failure each year (1-3). Iraproved survival rates of liver transplant recipients in the past
decade are due to many factors including iraproved surgical
techniques andraethodsof organ preservation, better selection
criteria for recipients, advances in understanding ofthe immune
.system, introduction of new imraunosuppressive agents, and increased knowledge in the prevention andraanageraentof potentially fatal coraplications (1,4-8).
Debility, raalnutrition, encephalopathy, andraassiveascites,
conditions associated with end-stage liver disease (ESLD), continue to be risk factors in transplantation (1). Accordingly, treatment ofthese condirions, which is largely dependent on proper
attention to nutrition, iraproves the probability of successful
transplantation (7,9-12).

L

Nutritional Assessment of the
Liver Transplant Candidate
In order to treat nutritional abnorraalities and malnutrition,
they
they must first be identified. The task of the dietitian working
with liver transplant patients is to coraplete the nutritional assessment which, at Baylor University Medical Center (BUMC),
occurs during the initial evaluation of a patient's suitability for
liver transplant. Deterraining the nutritional status of a pretransP'ant patientraaybe hampered by the effect of the liver disease
on the usual pararaeters of objecrive nutritional assessment.
These include body weight, anthropometric measureraents, urinary creatinine and 3-raethylhistidine excretion, nitrogen bailee, serura visceral protein levels, tests of delayed hypersensi'•vity, and the total lymphocyte count (TLC) (9,10,13-16).
Objective nutritional assessment parameters
The most coramonly used nutritional assessraent pararaeter i*^
bodly weight. However, weight measureraentraaynot be a valid
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nutritional index in patients with ESLD because ederaa, ascites,
and adrainistration of diuretics alter body weight (9,10,13). Loss
of lean bodyraassin a pretransplant patientraaybe masked by
concurrent fluid retention when body weight is used as the nutritional indicator.
Anthropometric measureraents (tricep skinfold and arra muscle circumference) have been proposed as more accurate than
body weight as markers of nutritional status in pretransplant patients (10,15). However, there areraulriplesources of error in
this procedure, including observer errors, instruraent errors, tissue corapartment changes, and inaccurate applicarion of the
raeasureraents (17). Another problem is that theraassof intemal
fat raay not always be proportional to that found in skinfolds,
and changes in total body waterraayhave an effect on skinfold
raeasureraents (18). Because available standards for anthroporaetricraeasurementsdo not account for variations in hydration and skin compressibility, they raay not be valid for use in
studies of comparisons of measureraents for patients with ESLD
(9,13). Anthropometricraeasureraentsare best used for assessraent of ESLD patients in long-term monitoring, with measureraents made by the same observer. They are not reliable as an initial nutritional assessraent index (9,13).
Creatinine-height index (CHI), another nutritional assessment parameter, is used toraeasurestatic protein reserves but
raay not be practical for evaluation of candidates for liver transplant. Malnutrition, aging, decreased bodyraass,and suboptiraal protein intake all can be altered in ESLD and will affect CHI
values (13,16). The hepatorenal syndrorae occurs with sorae
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frequency in the pretransplant population and also alters CHI
(13,14). The required 24-hour urine speciraens are difficult to
collect. In addition, levels of creatinine, araetaboliteof creatine
which is synthesized in the liver (19), are likely to be abnorraal
and cause an erroneous CHI raeasureraent.
Nitrogen balance studies, like CHI studies, require 24-hour
urine collections as well as concurrent records of protein intake.
Both are difficult to obtain unless subjects areraaintainedin a
controlled environment. The hepatorenal syndrome, which is
fairly comraon in patients with ESLD, leads to nitrogen retention in the forras of BUN and aramonia. Consequently, nitrogen
excretion is decreased, making a true nitrogen balance study unrealistic (9,13,20).
Three-methylhistidine in urine is a biochemical marker used
to estiraate protein stores. Mean 3-raethylhistidine values were
norraal in a study of 74 pre-liver transplant patients, although reduced muscleraassaffected the levels (16). Renal function, age,
sex, dietary intake, trauraa, and infection also affect 3-raethylhistidine excretion (21).
Protein status is often estiraated frora measurements of serura
levels of alburain, transferrin, prealburain, and retinol-binding
protein whose levels are coraraonly depressed in liver failure
(9,10,13,15,16,22). Levels of these serum proteins are affected
by the state of hydration, hepatic necrosis, renal insufficiency,
malabsorption, zinc deficiency, iron stores, or cortisone adrainistration (9,10,13). In ESLD, serura protein levels are not reliable
pararaeters for nutritional assessraent (9,10,13,15,16,20).
Iraraune function, often measured by skin antigen testing or
TLC, is used often as a nutritional indicator (21). Not only does
a depressed nutritional state irapair host defense, but in the presence of severe hepatic dysfunction inhibitory factors have been
identified which depress iraraune function (10). Skin antigen
testing and delayed hypersensitivity reaction are affected by
hepatic failure, electrolyte imbalance, infection, renal insufficiency, immunosuppressive raedications, andraetabolicstress
(13). Iramune function indicators are avoided as nutritional parameters in patients with ESLD because they are considered to
be imraunosuppressed (13).
Because these nutritional pararaeters are frequently altered by
variables other than nutrition (9,10,13-16,20), other indicators
have been suggested to determine the nutrirional status ofthese
parients. Clinical judgment must take into consideration diet
history and physical findings, as well as biochemical raeasurements (9,13,16).
Subjective nutritional assessment parameters
A "subjective" approach is used at BUMC to assess the nutritional state of liver transplant recipients. The technique was
adapted frora the original "subjective global assessraent" (SGA)
by Detsky et al (23) and focuses on information obtained frora
the patient as well as the dietitian's observations. The patient is
questioned about weight change (loss and/or gain of lean raass,
fatraass,or fluid accuraulation), nutritional intake, gastrointestinal syraptoras, physical capacity, and presence and duration of
other conditions that affect nutritional state. The information is
ranked into degrees of severity. For example, if the patient is
questioned about vomiting, the response is categorized as no
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vomiting, vomiting for less than one week, or vomiting f^^^
least one week. The observer assesses the degree of the patient
fat andrauscledepletion and degree of ascites or edema. Patients
are ranked as well nourished,raoderately(or suspected of being)
malnourished, or severelyraalnourished(according to the origj
nai SGA). Although this approach is dependent upon both pj
tient recall and the rater's skill, it has been found to be valid jj
surgical patients (23,24) and judged to be useful in liver trans,
plant candidates (25). In a study of 20 patients at BUMC, thj
raethod was found to have fair to good interrater reliability (25)

Prevalence of Malnutrition in
Liver Transplant Candidates
Malnutrition is coramon in ESLD patients (1,9,13,15,16,22),
Nutritional assessment of BUMC liver transplant candidates confirms these reports. Of 435 transplant candidates, 128 (29.4%)
were well nourished, 244 (56.1%)raoderately(or suspected of
being) malnourished, and 63 (14.5%) severely malnourished.
The prevalence of malnutrition in liver transplant recipients
underscores the need for appropriate nutritional care before and
after fiver transplantarion (9,10,13,22,26). These nutritional
needs can be described as short- and long-term requirements.

Variables Affecting Short-term
Posttransplant Nutritional Goals
The short-term posttransplant nutritional goal is anabolism.
Specific needs of the recipients are dependent on variables sucli
as present nutritional state, surgical procedures perforraed at the
tirae of transplant, effects of postoperative medications, and any
associated medical coraplications.
In a study of 74 liver transplant candidates, nutritional status
was found to vary with the type of liver disease (16). Ascites
was prevalent in patients with chronic active hepatitis, and caloric stores were often depleted while protein stores remained
within normal liraits. Patients with sclerosing cholangitis often
displayed only muscle wasting, while victiras with priraary biliary cirrhosis displayed marked fat and muscle wasting althougli
they retained good synthesis functions ofthe liver. Patients witn
any fulminant disease were stressed and acutely depleted. Indi'
vidual goals are dependent on the nutritional state which is
fluenced by the nature of the primary liver disease.
Another factor in individual nutritional care plans is the type
of transplant surgery. A choledochojejunostoray requires more
sraall bowelraanipulationthan does a choledochocholedochoS'
tomy and raay delay initiation of oral intake. A new transpl^"'
procedure called a "cluster" transplant has raany nutrition
raraifications. This procedure is indicated forraalignanciesi
volving not only the liver but also the pancreas, duodenum,
colon. The liver is reraoved with the patient's pancreas, duo
nura, spleen, proxiraal jejunura, storaach, andraostofthe coio"'
Organ cluster grafts of liver, pancreas, and duodenum are
placed (27). Sinceraanydigestive organs are reraoved, there' ^
high potential forraalabsorption,duraping syndrome, and g
cose intolerance.
,^
The third nutrition-influencing factor, medication, is ^ " ^ ^ " - i
able because imraunosuppressive dmgs are essential to pre i
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Table I
Side Effects of Immunosuppressive Medications Used in
Liver Transplantation
unosuppressiveDrug

Side Effeci

Iniff
Cyclosporin'^

Glucocorticoids

Its.

Azathioprine

0KT3

Nephrotoxicity (8.29.30-32)
Hepatotoxicity (30-32)
Hypertension (8.29,33)
Hyperlipidemia (31,34)
Hyperkalemia (28,31,33)
Magnesium wasting (8,31)
Hyperglycemia (20.31.35)
Gingival hypertrophy (31,36)
Hirsutism (31)
Tremor (31.33)
Paresthesias (31,33)
Headache (33)
Catabolism and impaired wound
healing (30,31)
Hyperglycemia (30,31,33.37)
Hyperlipidemia (31)
Sodium retention (30,31)
Electrolyte disturbances (30.31.33)
Increased appetite (31)
Increased calcuria (31,33)
Developmeni of peptic ulcers (31)
lncrea.sed hair growlh (31)
Acne(31)
Mood swings (31)
Nighl sweats (31)
Bruising of the skin (31)
Blurred vision (31)
Moon face (31)
Joinl pain (31)
Insomnia (31)
Increased sun sensitivity (31)
Developmeni of cataracts (31)
Nausea (31)
Vomiting (31)
Sore throat (31)
Altered taste acuity (31)
Macrocytic anemia (31)
Nausea (30,31)
Vomiting (30,31)
Diarrhea (30,31)
Loss of appetite (31)
Fever and chills (30.31)

organ rejection. These raedications include cyclosporine A
(CYA), steroids, azathioprine, and 0KT3 and have many nutritional side effects (8,20,28-37) (Table I). New immunosuppressive drugs currently under investigation include FK-506, RS61443, and rapamycin. Other comraonly used posttransplant
medications such as antacids, antibiotics, and diuretics can precipitate diarrhea, constipation, irapaction, nausea, voraiting, anorexia, polydipsia, and electrolyte irabalance (4,30,31,33).
Postoperative complications which affect decisions about nutrition include organ rejection, infection, acute renal failure, bil'*ry, intestinal, and pulmonary coraplications, hypotherraia,
*ound complications, and pancreatitis (2,4,6,29,32).
These various medical conditions affect nutrition. For example, ifa transplanted graft fails to function, another eraergency
fransplant may be required (32). During thetimefrom the initial
'0 the subsequent liver transplant, nutrition support is complicated by the inability of the nonfunctioning graft to metabolize
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nutrients. Acute rejection of a transplanted liver often requires
additional steroid administrarion which amplifies the side effects of these drugs. Chronic rejection may result in such severe
hepatic damage as to require reinstatement of nutritional principles for ESLD.
Transplant recipients are at highrisknot only for rejection but
also for infection. The high rate of infection in posttransplant patients may be affected by immunosuppression, the use of antibiotics, preoperative malnutririon, and/or antacids that perrait
bacterial overgrowth in the stomach (32). In the presence of
widespread infection or sepsis, nutritional needs are increased
and antibiotic therapy raay be initiated. Not only do the infection and fever affect appetite, but the antibiotics may produce
diarrhea, taste changes, and anorexia (31).
Renal function also affects nutritional needs. CYAraaybe
nephrotoxic and renal irapairraent occurs with sorae frequency
following liver transplant (6,32). Alterations in electrolyte therapy, a decrease in protein intake, and restriction of fluid intake to
raatch outputraaybe indicated.
Coraplications of other organ systeras such as pulraonary,
biliary, or intestinal tracts can require changes in types and
amounts of nutrients, but, more frequentiy, require a change in
the nutritional route. For example, ventilator support with intubation or occurrence of sraall bowel obstruction requires nutrition by other than oral raeans.
Hypotherraia is another reported postoperarive complication
of liver transplantation (6,20,32). The response to hypothermia
is shivering, vasoconstricrion, hyperventilation, and alkalemia,
with increased cardiac output and oxygen consumption (6). Increased oxygen consuraption and shivering increase the patient's
energy expenditure.
Wound complications also have nutrirional effects. The presence of a large open wound orraanydrain sites requires additional nutrition to corapensate for nutrient losses.
Pancreatitis occurs infrequentiy (4). Mild pancreatitis raay
only delay the onset of oral intake, but more severe attacks require bowel rest and total parenteral nutrition (TPN).

Short-term Posttransplant
Nutrient Requirements
Nutrient needs are increased imraediately posttransplantation. In one study of eight patients, mean resting energy expenditure (REE) rose 36% to 38% above the predicted resting energy expenditure (FREE) (based on the Harris-Benedict equation) on the first and second days after surgery (38). In another
study, measured REE was only 7% higher than FREE (27), but
FREEraayhave been overestimated by calculations eraploying
the patient's actual weight (including ascites) rather than dry
weight. When indirect calorimetry equipment is not available to
raeasure individual postoperative needs, caloric requireraents for
transplant patients may be estiraated at about 1.5 tiraes the basal
energy expenditure (BEE) using the Harris-Benedict equation.
A range of 140% to 170% of BEE is suggested, or 33 to 40 kcal
per kg of ideal body weight (20). At BUMC, the patient's lowest
recent weight is used to estiraate dry body weight for calculating
energy and protein needs.
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Table 2
Short- and Long-term Nutritional Needs of the Adult Liver Transplant Patient
Nutrient

Short-term Needs

IjOng-lerm Needs

Calories

1.4-1.7 X BEE (20.39)

Protein
Carbohydrate

1.5-2.0 g/kg (20.30.34)
50%-70% of nonprotein calories.
decrease if glucose is
elevated (30.39)
30%-50% of nonprotein calories,
decrease if triglycerides are
elevated (39)
Restrict fluid as needed for
edema/ascites (30,39)
Restrict to 2-4 g as needed
for edema/ascites (30,31,39)
Supplementation/restriction
depends on serum potassium
level
Supplemenl when low wiih 1
Slo-Mag tablet three
times a day
Supplement when low with 2
Neulra-Phos capsules three
limes a day
Supplement when low or in
females near menopausal age
or in olher patients with
hislory of bone deterioration*

Fat
Fluid
Sodium
Potassium
Magnesium

Phosphorus

Calcium

For weight mainlenance
aboul 1,2 X BEE (39)
0,8-1,0 g/kg (39)
No added sugar, low
concentrated carbohydrate
(20,30,39)
< 30% of calories as fat.
< 10% of calories as
saturated fal (39)
4 g (30,31,39)
Same as short-term plan
Encourage inlake of high magnesiumcontaining foods, supplemenl according
10 short-term plan
Encourage intake of high phosphoruscontaining foods, supplemenl
according lo short-lerm plan
Encourage inlake of high calciumcontaining foods, supplement
according lo short-term plan

* Women: Two Florical capsules three limes a day, one 0.25 |ig calcitriol capsule per day, 0.1 mg estradiol patch changed every
3 days and worn three out of four weeks. Men: exclude estradiol patch.

The hyperraetabolic postoperative transplant patient is in a
catabolic state. In a study of eight posttransplant patients, raean
nitrogen excretion (urinary urea nitrogen [UUN|)was found to
be 20.1 g on the first postoperative day and 24.6 g on the second
postoperative day (38). In another study, UUN excretion was
less than the previous study (12.9 ± 4.4 g/day), but it was raeasured on the third postoperative day (27). The large nitrogen
losses are due to steroid therapy,rausclecatabolisra in an unfed
state, and stress from surgery (27,30). A protein load of 1.3 to 2
g/kg of dry body weight is recoraraended (20,30). The BUMC
care plan calls for 1.5 g/kg.
Other nutritional changes after transplant must also be raonitored (39). Carbohydrate and fat are not restricted in the immediate postoperative period unless serura glucose and triglyceride
concentrations indicate intolerance. Sodium and fluid intake may
be restricted if a patient retains excess fluid (30). Attention to
electrolyte and mineral levels is mandatory. CYA can cause retention of potassium while sorae diuretics waste potassiura (Table I). Accelerated loss ofraagnesiurahas been associated with
both CYA (40,41) and diuretic therapy. Depleted semm magnesium levels may lead to tetany or seizures (8,31,40-42). Phosphorus and calcium may also require supplementation (Table 2).

Nutrition Support Following
Liver Transplantation
The urgent need for increased nutrients imraediately posttransplant may require special nutritional techniques. TPN is adrainistered to all liver transplant patients at some centers but is
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not used routinely at many others (20,30). At BUMC, TPN or
tube feeding (TF) is administered only to patients with one ot
more complications—severe raalnutrition, prolonged ileus or
ventilator dependence, persistent voraiting or diarrhea, inability
to eat adequately, or altered neurologic status affecting eating
(39). In 427 transplant patients at BUMC, 140 (32.7%) received;
some type of nutrition support; 38 (8.9%) received TF alone, 51
(11.9%) received TPN alone, and 51 (11.9%) received a combination of parenteral and enteral nutrition.
Nutrition support is used only as an altemative to oral diets.
When ileus resolves usually three to four days postoperatively,
the patient is advanced to an unrestricted general diet (32,39)
However, poor appetite, altered taste, and early satiety often
haraper the patient's ability to eat adequately (30). Freque"'
feedings, oral suppleraents, and additional raenu choices enhance the opportunity to achieve nutrirional goals. The adequacy of intake is monitored via calorie counts, and intake is
compared to the patient's esrimated needs (39).
If a patient has a functioning gastrointestinal tract but is unabl^
to consume an adequate diet or is at highriskfor aspiration, a snia>
bowel feeding tube is placed (9,30,32,39). Difficulties whi'*
can develop frora TF include diarrhea, volume overioad. depf^''^
sion of appetite, and restriction of physical mobility. Diarthe^
frequently reported complication, can haveraanyetiologiesMedications are comraon culprits. Magnesiura-containing antae
can be changed to alurainum-containing antacids. Althou,aha"'
tibiotics may cause diarrhea, their use cannot always be avoi"
Fiber-enriched TF formulas have been helpful in preventing
arrhea, and antidiarrhealraedicationsraaybe required.
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Volume restriction, necessary in a posttransplant patient who
(jevelopmS ^'^''^ overload, can be achieved through the use of
entrated forraulas, 1.5 and 2 kcal per raL.
'^'^physieal mobility can be hampered by the tube feeding equipbut noctumal feedings can allay this problem. Noctumal
feedings are favored when possible because the patient has raore
..ctricted ambularion and a better appetite during the waking
^irirestii
hours (9)[fa patient cannot tolerate a tube feeding or if enteral feedings
contraindicated by a nonfunctioning gastrointestinal tract
32), highriskof aspiration (9), sraall bowel obstruction, pancreatitis (4)^ or gastrointestinal fistulas, TPN is the nutritional
route of choice. Difficulties encountered with the initiation of
jpN include fluid overload, intolerance to nutrient substrates,
cholestasis, and electrolyte disturbances. When volume restriction is necessary, a concentrated nutrient forraula can be infused
via a line placed in a central vein. Patients may not tolerate large
amounts of intravenous protein, gluco.se, or lipids. Tolerance is
monitored by serum BUN, glucose, and triglyceride levels, and,
if anyrisedramatically, the amount of the corresponding nutrientmay be reduced. If hyperglycemia occurs, sliding-scale insulin may be given and insulin can be added to the TPN solution.
Standard amino acid solutions are provided to most posttransplant patients while high branched-chain araino acid forraulas
are reserved for encephalopathic patients.
Liver biopsy following liver transplantation reveals cholestasis in sorae cases. Cholestasis raay be secondary to ischeraic insult to the donor organ butraaybe exacerbated by excessive calories administered by TPN (27). Care not to overfeed patients
minimizes the potential for TPN-induced cholestasis (27).
Electrolyte disturbances which may also occur with TPN can
be avoided by dailyraonitoringof laboratory values and adjusting TPN forraulations.
Although TF or TPN may be required in the short-term posttransplant phase, the nutritional goal is anabolism, with an oral
diet as the route of choice.

Long-term Posttransplant
Nutritional Complications
Nutritional goals in the long-terra post liver transplant phase
are different frora those during the short-terra phase. Whereas
the short-terra goal is anabolism, long-term goals are raaintenance and prevention. Nutrition-related probleras which may
occur in the long terra after liver transplantation include excessive weight gain, hyperlipidemia, hypertension, diabetes, hyperkalemia, ederaa, and osteoporosis (20,29,30,43-45).
Posttransplant obesity occurs in nearly 40% of BUMC patients one year after liver transplant. In a study of 46 such patients at the Mayo Clinic, median long-terra weight gain was 6.5
1g
' (29). This weight gain is due to an increased apperite, good
liver function, steroid therapy, and an attitude of no restraint on
eating patterns (30).
The hyperlipidemia which is well documented in renal transplant recipients (37,46) seems to respond soraewhat to a low fat,
low cholesterol diet (37). Steroids and CYA have been irapli'^ated as possible inifiators of the hyperlipidemia (34,36). Fur-
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ther research is needed into the occurrence and manageraent of
hyperlipidemia in liver transplant recipients.
Hypertension occurs in 50% to 70% of posttransplant patients
(29,43,44). Antihypertensive drugs are often needed and mildly
restricted sodiura diets are encouraged (20,30).
New onset diabetes meOitus can also occur following a liver
transplant (29). This raay be due to steroid administration, but
recent studies implicate CYA as a diabetes-inducing agent (35,
45). Since the availability of CYA as a potent immunosuppressive drug, steroid dosages have been reduced witb little difference seen in the occurrence of diabetes mellitus (45). Studies
with rats suggest that glucose intolerance is a consequence of
CYA use, due to the simultaneous development of insulin resistance and inhibition of insulin secretion by beta cells (35).
Three long-terra nutritional complications are linked to medications. Hyperkalemia, edema, and osteoporosis result in part
from the use of iraraunosuppressive drugs. Hyperkaleraia occurs with CYA (31). Ederaa can be induced by both steroids and
CYA (31) while osteoporosis is a well-known consequence of
steroid adrainistration (31).

Long-term Posttransplant
Nutrient Requirements
Just as the nutritional goals and probleras in the short term
differ from those in the long term, so do the nutritional needs of
the liver transplant recipient also change. Calorie, protein, fat,
carbohydrate, sodium, potassiura, calcium, caffeine, alcohol,
and suppleraent needs are addressed by the dietitian for each
transplant patient (39).
In the long terra, caloric requirements dirainish to about
120% of the BEE for weightraaintenanceand protein needs decrease to approxiraately 0.8 to 1.0 g of protein per kg of body
weight. To reduce hyperiipideraia, fat intake is limited to less
than 30% of calories with restriction of saturated fat (20,30,39).
Siraple carbohydrate products should be eaten only occasionally and diabetic diets are instituted when diabetes occurs (20,
30,39). Sodiura intake should not exceed 3 to 4 g datiy to help
control blood pressure and fluid retention (20,30,39). If semra
potassium remains elevated, dietary restriction is indicated. Calcium must be adequate to compensate for an increased urinary
loss secondary to steroids (20,30,39). Intake of caffeine and alcohol is discouraged. Vitarain suppleraentation is not required
in most cases, and dosages of any nutrient above 200% of the
Recoraraended Dietary Allowance is discouraged (Table 2).

Nutritional Counseling Following
Liver Transplantation
Counseling by the transplant dieritian is essential to help liver
transplant recipients understand their changing nutrient needs.
Counseling is conducted forboth inpatients and outpatients. Inpatient counseling consists of daily rounds with the transplant
team and brief conversations with each patient about his/her current nutritional status and goals. Prior to hospital discharge, the
transplant dietitian forraally counsels the patient and family raerabers on attaining the interraediate and long-terra nutritional goals
(39). Outparient counseling includes individual counseling for
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specific nutrition problems and required classes for patients and
their families on the prevention of nutritional problems.

Conclusion
The nutritional needs of the liver transplant patient are ever
changing. Liver transplant parients frequently experience a
broad spectrum of nutritional problems. Obesity can occur in the
same patient who suffered frora raalnutrition at the rime of
transplant a year earlier. Although many questions reraain, attention to nutritional needs improves both the short- and longterra outcomes of the liver transplant recipient.
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